Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients.

2001

Objective: To evaluate the cost effectiveness of zanamivir 10mg twice daily for 5 days in the treatment of influenza in high-risk patients.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

27

References

33

Citations